About 100 reports

Abstract: - Global Neglected Tropical Diseases Diagnosis Market to Reach $7.9 Billion by 2027 - Amid the COVID-19 crisis, the global market for Neglected Tropical Diseases Diagnosis estimated at US$6 Billion in the year 2020, is projected to reach a revised size of US$7.9 Billion by 2027, growing at aCAGR of 4% over...

  • Tropical Disease
  • Diagnostics
  • World
  • China
  • United States

##.## Tropical Disease Testing

  • Point Of Care Testing
  • North America
  • Drug Approval
  • Laboratory Revenue

##.## Increasing government funding for the use of POC in tropical disease testing will support market growth

  • Diagnostics
  • World
  • North America
  • Latin America
  • Drug Approval
  • Diabetes Prevalence

Point of Care POC Infectious Disease Diagnostics Market Size, Outlook and Growth Opportunities, 2019- 2025 Global POC Infectious Disease Diagnostics Market Size, Outlook and Growth Opportunities to 2025: By Technology( Lateral Flow, Agglutination Assays, Flow Through, Solid Phase, and Others), By Application( Tropical...

  • Infectious Disease
  • Managed Care
  • Diagnostics
  • World
  • APAC
  • Asia
  • Europe
  • North America
  • Middle East
  • Africa
  • Latin America
  • Health Expenditure

International Stem Cell United States World Research And Development Pharmaceutical Healthcare Drug Delivery Regenerative Medicine Tropical Disease

  • Biotechnology
  • Pharmaceutical
  • Infectious Disease
  • North America
  • Freezer Sales
  • Energy Consumption

Figure ##. Global Tropical Disease Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

  • Point Of Care Testing
  • World
  • Indiana
  • Diabetes Prevalence
  • Cancer Incidence

The TT##CL consortium announced that it has been awarded EUR ## million to develop an oral treatment, D##, against one of the most neglected tropical diseases, cutaneous leishmaniasis.

  • Autoimmune Disease
  • United States
  • Prescription Drug Sales
  • Medical Technology Density

Point Of Care (PoC) Diagnostics Market Size, Outlook and Growth Opportunities, 2019- 2025 Global POC Disease Diagnostics Market Size, Outlook and Growth Opportunities to 2025: By Product( Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products,...

  • Diagnostics
  • Managed Care
  • World
  • APAC
  • Asia
  • Europe
  • North America
  • Middle East
  • Africa
  • Latin America
  • Health Expenditure

Biomeme will supply its mobile molecular point-of- need testing technology Franklin qPCR thermocycler and reagents to diagnose neglected tropical diseases (NTDs) and other infectious diseases like COVID-##.

  • Healthcare
  • Molecular Diagnostics
  • Healthcare IT
  • Application
  • World
  • North America
  • Europe
  • APAC
  • Health Expenditure
  • Drug Approval

Society of Infectious and Tropical Diseases

  • Blood Supply
  • Household Refrigerator
  • Laboratory
  • North America
  • United States
  • Canada
  • Mexico
  • Household Refrigerator Sales
  • Energy Consumption

In 2017, the GHIT received USD ## million in funding, part of which is expected to be used to develop new diagnostics for infectious diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases (NTDs).

  • Diagnostics
  • United States
  • Europe
  • APAC
  • North America
  • Infectious Disease Incidence
  • Health Expenditure

Tropical Diseases

  • Infectious Disease
  • Diagnostics
  • World
  • United States
  • Europe
  • APAC
  • North America
  • Health Expenditure
  • Drug Approval

Oblita Therapeutics announced that D## is eligible to receive a FDA Priority Review Voucher upon its approval for the treatment on Leishmaniasis or another Neglected Tropical Disease.

  • Autoimmune Disease
  • Infectious Disease
  • Drug Development
  • United States
  • Medical Technology Density
  • Rural Population

This funding reimburses costs incurred during R&D. In 2017, the GHIT received USD ## million in funding, part of which is expected to be used to develop new diagnostics for infectious diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases (NTDs).

  • In Vitro Diagnostic Reagent
  • China
  • United States
  • APAC
  • Europe
  • North America
  • Health Expenditure
  • Infectious Disease Incidence

The TT##CL consortium announced that it has been aw arded EUR ## million to develop an oral treatment, D##, against one of the most neglected tropical diseases, cutaneous leishmaniasis.

  • Autoimmune Disease
  • United States
  • Medical Technology Density
  • Rural Population

In June 2013, Aix-Marseille Universite filed a patent EP##.## titled "A new chemical family to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Infectious Disease
  • World
  • Japan
  • Hawaii
  • South Africa
  • Drug Approval
  • Health Provider Density

In June 2013, Aix-Marseille Universite filed a patent EP##.## titled "A new chemical family to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Infectious Disease
  • United States
  • Japan
  • Drug Approval
  • Pharmaceutical Registrations

It had been concluded in the meeting that atopic dermatitis is the most prevalent chronic inflammator y skin disease in SSA. Besides neglected tropical diseases (NTDs) with a dermatological presentation, AD requires closer attention from the WHO and national Departments of Health.

  • Dermatological Condition
  • Pharmaceutical
  • United States
  • Europe
  • APAC
  • Africa
  • Health Expenditure
  • Drug Approval

In September 2010, Themis Bioscience formed a joint R&D program collaboration with Institut Pasteur to fight tropical infectious diseases including chickungunya.

  • Infectious Disease
  • World
  • India
  • Hawaii
  • Drug Approval
  • Surgical Procedures Performed

For instance, the Italian Society of Infectious and Tropical Diseases (SIMIT) represented physicians, scientists and other healthcare professionals that specialize in the infectious diseases with an aim to improve the diagnosis, treatment and prevention of these diseases.

  • Infectious Disease
  • APAC
  • World
  • United States
  • Europe
  • North America
  • Drug Approval
  • Health Expenditure

The company stated that ATI-## is eligible for a Neglected Tropical Disease Priority Review Voucher if first approved by the U.S. Food and Drug Administration (FDA) for the treatment of cryptococcal meningitis

  • Infectious Disease
  • Toyama Prefecture
  • South Africa
  • Shaanxi
  • Indiana
  • Drug Approval
  • HIV AIDS Prevalence

Eisai Enters Into Co-Development Agreement With Broad Institute For Neglected Tropical Diseases And Tuberculosis

  • Pathology
  • Genomics
  • Pharmaceutical
  • Healthcare
  • Antiviral
  • Massachusetts
  • Japan
  • World
  • Drug Approval
  • Pharmaceutical Exports

The initial focus is on developing rapid diagnostic tests to identify and distinguish specific neglected tropical diseases from each other and to create a superior next generation HIV test.

  • In Vitro Diagnostics
  • World
  • United States
  • Cervical Cancer Screening Coverage
  • Diagnostic Revenue

In April 2017, it was announced that the Mexico becomes first in the American region to wipe out the tropical eye disease.

  • Eyewear
  • World
  • APAC
  • United States
  • Elderly Population
  • Eye Diseases Prevalence

Dr. Rogelio López-Vélez, head of the National Referral Unit for Tropical Diseases of the Ramón y Cajal University Hospital in Madrid, Spain, said, "The positive opinion of the CHMP for the approval of this single-dose oral cholera vaccine is excellent news for all those who are dedicated to the practice of Travel Medicine.

  • Infectious Disease
  • Pharmaceutical
  • World
  • United States
  • Drug Approval
  • Infectious Disease Prevalence

Alere's product portfolio majorly includes rapid diagnostics systems, including benchtop analyzers and rapid tests in the areas of infectious disease testing (HIV, malaria, dengue fever, and many other tropical diseases), molecular POC testing for RSV, influenza A & B, and strep A, cardiometabolic testing including Afinion and Cholestech platforms and tests.

  • Diagnostics
  • United States
  • Diabetes Prevalence
  • Drug Approval

Impavido® (miltefosine) is the first and only oral treatment approved by the FDA for visceral, mucosal and cutaneous leishmaniasis (a rare tropical parasitic disease).

  • Infectious Disease
  • Therapy
  • World
  • United States
  • Mortality Rate
  • Cash Transactions

Dr. Rogelio López-Vélez, head of the National Referral Unit for Tropical Diseases of the Ramón y Cajal University Hospital in Madrid, Spain, said, "The positive opinion of the CHMP for the approval of this single-dose oral cholera vaccine is excellent news for all those who are dedicated to the practice of Travel Medicine.

  • Infectious Disease
  • World
  • United States
  • Drug Approval
  • Infectious Disease Prevalence

DNDi Enters Into Co-Development Agreement With Abbott Labs For Neglected Tropical Diseases

  • Pharmaceutical
  • Healthcare
  • Private Placement
  • Russia
  • Indiana
  • Drug Approval
  • Diabetes Prevalence

Ebola, neglected tropical diseases, influenza, Japanese encephalitis, epidemic preparedness

  • Infectious Disease
  • Vaccine
  • United States
  • European Union
  • Infectious Disease Mortality
  • Gross Domestic Product